Stocktoria

Chugai Pharmaceutical Co., Ltd. 4519.T

JP · Tokyo Stock Exchange · XTKS · stock · Healthcare · website

Chugai Pharmaceutical Co., Ltd. statistics & valuation

Market cap¥11.41T
P / S9.1×
P / B5.6×
P / FCF41.5×
Dividend yield2.62%
FCF margin21.8%
Return on capital29.1%
Graham number -61.2%¥2,702.53

Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value (¥2,702.53); a green figure means the price is below it.

Profitability & efficiency

Gross margin (%)
62.20% 62.80% 71.00% 71.10% 2022202320242025
Operating margin (%)
42.30% 39.50% 46.30% 47.60% 2022202320242025
Return on equity (%)
2022202320242025
Shares outstanding
1.65B 1.65B 1.65B 1.65B 2022202320242025
Net debt (¥)
2022202320242025
Share buybacks (¥)
¥5.0M ¥5.0M ¥10.0M ¥6.0M 2022202320242025
Return on assets (%)
2022202320242025
Free cash flow margin (%)
13.70% 30.20% 33.50% 21.80% 2022202320242025
Debt / equity (×)
2022202320242025
EPS (¥)
¥227.57 ¥197.80 ¥235.36 ¥263.72 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Chugai Pharmaceutical Co., Ltd. trades at about 26.4× earnings — near its 10-year norm (10-year range 14.8×–33.4×, median 28.6×).

14.8× 33.4×

Shaded band = 10-year range (14.8×–33.4×); dot = today's 26.4×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin71.1%71.0%62.8%62.2%
Operating margin47.6%46.3%39.5%42.3%
FCF margin21.8%33.5%30.2%13.7%
Current ratio4.235.534.743.15

Computed from company filings · JP · as of 2025-12-31. Figures in JPY. Facts plus Stocktoria's own computed scores — not investment advice.